Pulmonary disease following intravesical BCG treatment.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2218978.
- Also identified by PMC identifier 462706.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bacillus Calmette-Guérin (BCG) is an attenuated strain of Mycobacterium bovis that has been used in the treatment of malignant disease for over 20 years and for the treatment of bladder cancer since 1976. Major complications of this treatment are infrequent. We report two cases of systemic illness with pulmonary manifestations after treatment with intravesical BCG.
Medical subject headings
- BCG Vaccine
- Carcinoma, Transitional Cell
- Tuberculosis
- Urinary Bladder Neoplasms